Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,477 | 66,926 | 68,053 | 65,675 | 22,263 |
| Marketable Securities | 230,750 | 189,797 | 152,389 | 157,994 | 169,752 |
| Receivables | 57,262 | 44,049 | 23,109 | 10,614 | 7,511 |
| TOTAL | $339,893 | $305,677 | $247,626 | $237,819 | $206,115 |
| Non-Current Assets | |||||
| PPE Net | 8,383 | 8,616 | 7,870 | 8,049 | 8,070 |
| Investments And Advances | 22,272 | 32,186 | 77,047 | 70,038 | 43,321 |
| Other Non-Current Assets | 8,537 | 8,175 | 8,176 | 10,731 | 18,331 |
| TOTAL | $39,192 | $48,977 | $93,093 | $88,818 | $69,722 |
| Total Assets | $379,085 | $354,654 | $340,719 | $326,637 | $275,837 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,902 | 4,696 | 3,268 | 3,714 | 5,488 |
| Accrued Expenses | 9,127 | 7,041 | 5,697 | 7,970 | 5,634 |
| TOTAL | $14,029 | $17,117 | $19,222 | $20,982 | $11,122 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,155 | 4,135 | 3,918 | 3,979 | 3,849 |
| TOTAL | $4,155 | $4,135 | $3,918 | $3,979 | $3,849 |
| Total Liabilities | $18,184 | $21,252 | $23,140 | $24,961 | $14,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,378 | 19,268 | 19,161 | 19,126 | 19,090 |
| Common Shares | 194 | 193 | 191 | 191 | 191 |
| Retained earnings | 89,937 | 69,649 | 57,094 | 45,356 | 8,848 |
| Other shareholders' equity | -595 | -794 | -458 | -112 | -137 |
| TOTAL | $360,901 | $333,402 | $317,579 | $301,676 | $260,866 |
| Total Liabilities And Equity | $379,085 | $354,654 | $340,719 | $326,637 | $275,837 |